At Fresenius Kabi, we offer a comprehensive solution for Canadian hospitals and clinics seeking compounding excellence. Backed by the highest commitment to product quality and safety, Fresenius Kabi has been providing patients with a wide range of ready-to-administer intravenous (IV) medications for over 20 years in Canada.
In October 2018, Fresenius Kabi Canada announced the opening of its new, state-of-the-art compounding plant located in Mississauga, Ontario. With over 20 compounding centres worldwide, and leveraging our 30 years of global expertise, the new compounding plant features some of the most advanced technology currently available. Our goal with this new facility is to meet the evolving needs of our healthcare partners and to support the growing demand of sterile compounded medications across the country.